Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Zymosense awarded $92,000 NSF RuralSTAMINA grant to advance phytase measurement nanotechnology commercialization.
PRIVATESep 08, 2026•about 3 hours ago
Amount Raised
$92,000
Round Type
Pre-Seed
AmesBiotechnology
Investors
Nsf Rural Stamina Biomanufacturing Engine
Description
Zymosense, Inc. has received a $92,000 commercialization grant from the NSF RuralSTAMINA Biomanufacturing Engine to advance its nanotechnology-enabled method for measuring phytase activity. The grant will support technical validation and commercialization efforts aimed at reducing risk and strengthening industry partnerships. Zymosense's platform measures enzyme function rather than simply detecting presence, providing more actionable information for phytase producers and users in agricultural and biomanufacturing markets
Company Information
Company
Zymosense
Location
Ames, Iowa, United States
About
Zymosense is a pioneering nanotechnology firm specializing in enzyme activity measurement solutions. The company's groundbreaking mobile mix and read assay technology offers a simple, fast, and reliable method for enzyme analysis, driving innovation in biotechnology and beyond.
Don't miss Zymosense's next move
Get an email the moment Zymosense raises, hires an exec, or expands, usually minutes after it happens.
AmesBiotechnology